I believe the second link should be:Bill C-442 is carried as is in Senate. Hear testimony in Canada’s Senate Committee on Bill C-442, An Act respecting a Federal Framework on Lyme Disease, as Bill moves forward.
Posted on December 10, 2014 by Canlyme
Bill C-442 is carried in the Senate:
Listen to testimony of ;
December 3rd, 2014
Elizabeth May, MP (begins after intro’s)
Jim Wilson, CanLyme (starts at 56:18 on time-bar)
Dr. William Bowie, AMMI, (starts at 1:03:55 on time-bar)
http://senparlvu.parl.gc.ca/Guide.aspx? ... ntid=14740#
December 10th, 2014,
Dr. Marc Oulette, CIHR, Dr. Stephen Sternthal, PHAC, Dr. Robbin Lindsay, NML Listen to audio here
http://senparlvu.parl.gc.ca/Guide.aspx? ... ntid=14740#
(To hear clause by clause vote scroll to 55:00 on the time-bar)
http://senparlvu.parl.gc.ca/Guide.aspx? ... ntid=15559
Alternatively, here's a CPAC link that will take you directly to a video recording of events on December 3, 2014:
http://www.cpac.ca/en/programs/in-commi ... s/35998245
I’m not sure how long it will take for the CPAC video recording of the December 10th committee meeting to become available.In Committee from the Senate of Canada
Social Affairs, Science and Technology - December 3, 2014
Green Party Leader Elizabeth May presents her private member’s bill (C-442) to establish a federal framework on Lyme disease. The bill was first introduced in 2012 and aims to increase awareness and prevention of the disease. It would create a national surveillance system, as well as a national educational program. Senators also hear from Jim Wilson, president and founder of the Canadian Lyme Disease Foundation, and doctors William Bowie and Daniel Gregson, who are speaking on behalf of the Association of Medical Microbiology and Infectious Diseases Canada. (December 3, 2014)
Edited to add:
Senator Ogilvie is no slouch when it comes to science and innovation, as you’ll see from the following biography:
http://www.parl.gc.ca/SenatorsBio/senat ... language=E
The Honourable Kelvin K. Ogilvie, C.M., Ph.D., D.Sc., H.Col., F.C.I.C ., Senator, was (1993–2003) President and Vice-Chancellor of Acadia University in Wolfville, Nova Scotia where he led the development and implementation of the acclaimed Acadia Advantage Program which was recognized by, and incorporated into, the Permanent Collection of the Smithsonian Institute in Washington, DC in 1999. He is a leading expert on biotechnology, bioorganic chemistry and genetic engineering. His scientific accomplishments include the development of the “Gene Machine”, an automated process for the manufacture of DNA. He is the inventor of Ganciclovir, a drug used worldwide to fight infections that occur when one’s immune system is weakened. Both of these achievements were recognized in 2000 as "Milestones of Canadian Chemistry in the 20th Century" by the Canadian Society of Chemistry. He also developed a general method for the chemical synthesis of large RNA molecules, demonstrated by the first total chemical synthesis or a functional Transfer RNA (tRNA) molecule, which is still the basis for RNA synthesis worldwide.
[snip]
Dr. Ogilvie was inducted into the Canadian Science and Engineering Hall of Fame in Ottawa in November, 2011 and received the Biomedical Science Ambassador Award in May 2012 in Ottawa awarded by Partners in Research. In November 2013 (Montreal) Senator Ogilvie received the Rx&D Health Research Foundation Medal of Honour for his outstanding contributions to health sciences and public health innovation.